These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 8118593)

  • 1. Implantable cardioverter defibrillator.
    Mickleborough LL
    Adv Card Surg; 1994; 5():209-30. PubMed ID: 8118593
    [No Abstract]   [Full Text] [Related]  

  • 2. Indications for implantable cardioverter defibrillator (ICD) therapy. Study Group on Guidelines on ICDs of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology.
    Hauer RN; Aliot E; Block M; Capucci A; Lüderitz B; Santini M; Vardas PE;
    Eur Heart J; 2001 Jul; 22(13):1074-81. PubMed ID: 11428848
    [No Abstract]   [Full Text] [Related]  

  • 3. Application of new pacemaker and defibrillator technology.
    Shepard RB; Epstein AE; Kay GN
    Adv Card Surg; 1994; 5():181-208. PubMed ID: 8118592
    [No Abstract]   [Full Text] [Related]  

  • 4. Indications for implantable cardioverter defibrillator (ICD) therapy.
    Hauer RN; Aliot E; Block M; Capucci A; Lüderitz B; Santini M; Vardas PE;
    Europace; 2001 Jul; 3(3):169-76. PubMed ID: 11467456
    [No Abstract]   [Full Text] [Related]  

  • 5. The evolution and revolution of the implantable cardioverter defibrillator.
    Indik JH
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):461-4. PubMed ID: 15225105
    [No Abstract]   [Full Text] [Related]  

  • 6. [Inappropriate therapy of an implantable cardioverter-defibrillator--is it always an undesired event?].
    Oreziak A; Przybylski A
    Kardiol Pol; 2009 Aug; 67(8):930-1. PubMed ID: 19885986
    [No Abstract]   [Full Text] [Related]  

  • 7. Implantable cardioverter defibrillators in children.
    Chun TU; Collins KK; Dubin AM
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):561-71. PubMed ID: 15225115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Who should receive the subcutaneous implanted defibrillator?: The subcutaneous implantable cardioverter defibrillator (ICD) should be considered in all ICD patients who do not require pacing.
    Poole JE; Gold MR
    Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1236-44; discussion 1244-5. PubMed ID: 24347599
    [No Abstract]   [Full Text] [Related]  

  • 9. New generations of implantable pacemaker defibrillators for ventricular and atrial tachyarrhythmias.
    Saksena S; Prakash A; Madan N; Giorgberidze I; Munsif AN; Mathew P; Kaushik R; Krol RB
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():149-54. PubMed ID: 8734177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [From implantable cardioverter-defibrillator to cardiac resynchronization therapy with the use of epicardial left ventricular lead. The evolution of the treatment of post inflammatory heart failure--a case report].
    Gepner K; Sterliński M; Przybylski A; Maciag A; Kołsut P; Szwed H
    Kardiol Pol; 2006 Oct; 64(10):1113-7. PubMed ID: 17089244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of device therapy for ventricular arrhythmias.
    Holley LK
    Heart Lung Circ; 2007 Jun; 16(3):162-9. PubMed ID: 17446124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost advantage of different cardioverter-defibrillator devices.
    Veenhuyzen GD
    J Am Coll Cardiol; 2006 Jul; 48(2):418-9; author reply 419. PubMed ID: 16843205
    [No Abstract]   [Full Text] [Related]  

  • 14. Advantages of a subcutaneous implantable cardioverter-defibrillator in LAMP2 hypertrophic cardiomyopathy.
    Zaki A; Zaidi A; Newman WG; Garratt CJ
    J Cardiovasc Electrophysiol; 2013 Sep; 24(9):1051-3. PubMed ID: 23577876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the treatment of arrhythmias: implantable cardioverter-defibrillators.
    Groh WJ; Foreman LD; Zipes DP
    Am Fam Physician; 1998 Jan; 57(2):297-307, 310-2. PubMed ID: 9456993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spanish Implantable Cardioverter-Defibrillator Registry. Sixth official report of the Spanish Society Of Cardiology Working Group on Implantable Cardioverter-defibrillators (2009).
    Alzueta J; Linde A; Barrera A; Peña J; Peinado R
    Rev Esp Cardiol; 2010 Dec; 63(12):1468-81. PubMed ID: 21144407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
    Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overdrive pacing suppresses ectopy and minimizes left ventricular assist device suction events.
    Ambardekar AV; Lowes B; Cleveland JC; Brieke A
    Circ Heart Fail; 2009 Sep; 2(5):516-7. PubMed ID: 19808384
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dual-chamber implantable automatic defibrillators. Experiences apropos of 16 cases].
    Le Franc P; Klug D; Lacroix D; Kouakam C; Jarwé M; Kacet S
    Arch Mal Coeur Vaiss; 1998 Jun; 91(6):739-44. PubMed ID: 9749190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Audible implantable cardioverter defibrillator alarms detect intermittent conductor discontinuity.
    Sheth N; Mahmood K; Singh B; Carter-Adkins D; Pachulski RT
    Can J Cardiol; 2002 Apr; 18(4):430-2. PubMed ID: 11992137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.